Biogaia

Biogaia CROIC

The Cash Return on Invested Capital (CROIC) of Biogaia (BIOG B.ST) as of Nov 21, 2026 is 22.93 %. In the previous year, Cash Return on Invested Capital (CROIC) was 20.74 % — a change of 10.56% (higher).

CROIC

22.93 %

YoY

10.56%

Last updated:

Cash Return on Invested Capital (CROIC) of Biogaia is 2025 22.93 % . Cash Return on Invested Capital (CROIC) of Biogaia was 2024 20.74 % . It decreases by 10.56% higher compared to the previous year.

The Biogaia CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2018
35.34 SEK
Jan 1, 2019
20.38 SEK
Jan 1, 2020
11.55 SEK
Jan 1, 2021
11.42 SEK
Jan 1, 2022
15.14 SEK
Jan 1, 2023
18.50 SEK
Jan 1, 2024
20.74 SEK
Jan 1, 2025
22.93 SEK
The Biogaia CROIC history
YEARCROICYoY
22.93 %+10.56%
20.74 %+12.12%
18.50 %+22.20%
15.14 %+32.62%
11.42 %-1.20%
11.55 %-43.31%
20.38 %-42.33%
35.34 %-22.97%
45.87 %+26.80%
36.18 %+59.88%
22.63 %-21.97%
29.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biogaia Stock analysis

What does Biogaia do? BioGaia AB generates revenue through its probiotic product segments, primarily featuring Limosilactobacillus reuteri strains. The Paediatrics segment sells drops, gut health tablets, oral rehydration solutions, and cultures for licensee products. The Adult Health segment offers gut health tablets, oral health lozenges, and cultures integrated into dairy products by licensees. The Other segment includes royalties from development projects and revenue from CapAble's packaging solutions. Products are marketed globally to consumers seeking health benefits from probiotics, with licensees distributing branded items under agreements. The company targets health-conscious consumers through direct sales and licensed partnerships. Paediatrics products focus on infant and child health, while Adult Health products address digestive and oral wellness. CapAble, a subsidiary, contributes through packaging solutions, and royalties from development projects provide additional income streams. All segments operate under BioGaia's brand, leveraging documented health benefits of their probiotic strains. Biogaia is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biogaia stock

Cash Return on Invested Capital (CROIC) of Biogaia is 22.93 % in 2025.

Cash Return on Invested Capital (CROIC) of Biogaia changed from 20.74 % to 22.93 %, representing a 10.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Biogaia since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Biogaia with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Biogaia

All Key Metrics — Biogaia